Impact of Elevated Lipoprotein(a) on Cardiovascular Events in Patients With Premature ASCVD: A Nationally Representative Sample of U.S. Medicare, Medicaid, and Commercial Enrollees

Accepted for presentation at American Heart Association. Findings available upon request. Contact us for more information.

Previous PostThe Association Between Average Sales Price Decline and Shortages in Small Molecule Injectable Oncology Therapies With Generic Competition
Next PostGender, Race, and Socioeconomic Disparities on Surgical Device-Aided Therapies (DATs) Among Medicare Beneficiaries With Advanced Parkinson’s Disease (aPD)

Harness the power of data to improve healthcare outcomes and economics.